Medicine and Dentistry
Acute Coronary Syndrome
40%
Angiography
17%
Antithrombotic
27%
Aortic Stenosis
59%
Aortic Valve
17%
Aortic Valve Replacement
15%
Aortic Valvuloplasty
13%
Atrial Fibrillation
30%
Base
16%
Body Mass Index
15%
C Reactive Protein
13%
Cardiac Troponin
48%
Cardiovascular Disease
14%
Cardiovascular Disease Risk Factor
13%
Cardiovascular Imaging
13%
Cardiovascular System
36%
Combination Therapy
18%
Computed Tomography Angiography
18%
Computer Assisted Tomography
52%
Coronary Angiography
66%
Coronary Artery Disease
58%
Coronary Computed Tomography Angiography
21%
Diabetes
21%
Diagnosis
36%
Diagnostic Accuracy
29%
Emergency Department
37%
Fibrillation
27%
Hazard Ratio
22%
Heart Muscle Injury
53%
Heart Muscle Revascularization
26%
In-Stent Restenosis
13%
Injury
13%
Major Adverse Cardiac Event
47%
Maturity Onset Diabetes of the Young
27%
Morbid Obesity
13%
Multidetector Computed Tomography
13%
Myocardial Disease
15%
Myocardial Infarction
100%
Percutaneous Aortic Valve Replacement
48%
Percutaneous Coronary Intervention
21%
Placebo
22%
Randomized Clinical Trial
29%
Revascularization
66%
Sex Difference
13%
Stable Angina Pectoris
16%
Stenosis
29%
Technology Assessment
13%
Thorax Pain
16%
Troponin
56%
Troponin T
48%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Coronary Syndrome
27%
Acute Heart Infarction
12%
Adenosine
6%
Adverse Event
7%
Alirocumab
50%
All Cause Mortality
5%
Anticoagulant Agent
13%
Antivitamin K
13%
Atrial Fibrillation
9%
Cardiovascular Disease
21%
Cerebrovascular Accident
10%
Chronic Kidney Failure
13%
Cohort Study
5%
Congestive Heart Failure
5%
Coronary Artery Disease
17%
Evolocumab
55%
Ezetimibe
16%
Frailty
13%
Heart Infarction
68%
Heart Muscle Injury
37%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
7%
Hypercholesterolemia
13%
Impaired Glucose Tolerance
6%
Lipoprotein A
27%
Low Density Lipoprotein Cholesterol
55%
Major Adverse Cardiac Event
13%
Non Insulin Dependent Diabetes Mellitus
27%
Physical Disease by Body Function
6%
Placebo
48%
Proprotein Convertase 9
20%
Randomized Controlled Trial
13%
Sitagliptin
13%
Statin (Protein)
45%
Troponin
38%
Troponin T
18%
Unstable Angina Pectoris
6%
Nursing and Health Professions
Acute Heart Infarction
5%
Advisory Committee
13%
Ankle Brachial Index
13%
Anticoagulant Agent
13%
Antivitamin K
13%
Aortic Stenosis
13%
Atrial Fibrillation
5%
Base
14%
Biomedical Technology Assessment
13%
Clinical Audit
13%
Clinical Decision Making
13%
Combination Therapy
13%
Confidence Interval
16%
Coronary Angiography
13%
Diagnosis
13%
Fractional Flow Reserve
27%
Health Care
13%
Heart Infarction
27%
Heart Muscle Injury
27%
Heart Surgery
13%
In-Stent Restenosis
13%
Injury
13%
Intermittent Claudication
13%
International Normalized Ratio
13%
Limit of Quantitation
5%
Major Adverse Cardiac Event
9%
Multidetector Computed Tomography
13%
Odds Ratio
9%
Percutaneous Coronary Intervention
13%
Reimbursement
13%
Revascularization
18%
Standard
13%
Transcatheter Aortic Valve Implantation
13%
Treatment Outcome
15%
Troponin T
5%
